PMID- 21841000 OWN - NLM STAT- MEDLINE DCOM- 20111209 LR - 20220309 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 286 IP - 40 DP - 2011 Oct 7 TI - L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. PG - 34800-8 LID - 10.1074/jbc.M111.235473 [doi] AB - Nonalcoholic fatty liver disease is one of the most common liver diseases. L-tryptophan and its metabolite serotonin are involved in hepatic lipid metabolism and inflammation. However, it is unclear whether L-tryptophan promotes hepatic steatosis. To explore this issue, we examined the role of L-tryptophan in mouse hepatic steatosis by using a high fat and high fructose diet (HFHFD) model. L-tryptophan treatment in combination with an HFHFD exacerbated hepatic steatosis, expression of HNE-modified proteins, hydroxyproline content, and serum alanine aminotransaminase levels, whereas L-tryptophan alone did not result in these effects. We also found that L-tryptophan treatment increases serum serotonin levels. The introduction of adenoviral aromatic amino acid decarboxylase, which stimulates the serotonin synthesis from L-tryptophan, aggravated hepatic steatosis induced by the HFHFD. The fatty acid-induced accumulation of lipid was further increased by serotonin treatment in cultured hepatocytes. These results suggest that L-tryptophan increases the sensitivity to hepatic steatosis through serotonin production. Furthermore, L-tryptophan treatment, adenoviral AADC introduction, and serotonin treatment induced phosphorylation of the mammalian target of rapamycin (mTOR), and a potent mTOR inhibitor rapamycin attenuated hepatocyte lipid accumulation induced by fatty acid with serotonin. These results suggest the importance of mTOR activation for the exacerbation of hepatic steatosis. In conclusion, L-tryptophan exacerbates hepatic steatosis induced by HFHFD through serotonin-mediated activation of mTOR. FAU - Osawa, Yosuke AU - Osawa Y AD - Departments of Informative Clinical Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. osawa-gif@umin.ac.jp FAU - Kanamori, Hiromitsu AU - Kanamori H FAU - Seki, Ekihiro AU - Seki E FAU - Hoshi, Masato AU - Hoshi M FAU - Ohtaki, Hirofumi AU - Ohtaki H FAU - Yasuda, Yoichi AU - Yasuda Y FAU - Ito, Hiroyasu AU - Ito H FAU - Suetsugu, Atsushi AU - Suetsugu A FAU - Nagaki, Masahito AU - Nagaki M FAU - Moriwaki, Hisataka AU - Moriwaki H FAU - Saito, Kuniaki AU - Saito K FAU - Seishima, Mitsuru AU - Seishima M LA - eng GR - R01 AA020172/AA/NIAAA NIH HHS/United States GR - R01 DK085252/DK/NIDDK NIH HHS/United States GR - R01 DK085252-01A1/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110812 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Lipids) RN - 0 (Triglycerides) RN - 30237-26-4 (Fructose) RN - 333DO1RDJY (Serotonin) RN - 343-65-7 (Kynurenine) RN - 8DUH1N11BX (Tryptophan) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 4.1.1.28 (Aromatic-L-Amino-Acid Decarboxylases) SB - IM MH - Adenoviridae/metabolism MH - Animal Feed MH - Animals MH - Aromatic-L-Amino-Acid Decarboxylases/metabolism MH - Fatty Liver/pathology MH - Fibrosis MH - Fructose/metabolism MH - Genetic Predisposition to Disease MH - Hepatocytes/metabolism MH - Kynurenine/metabolism MH - Lipids/chemistry MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Serotonin/metabolism MH - TOR Serine-Threonine Kinases/*metabolism MH - Triglycerides/metabolism MH - Tryptophan/*metabolism PMC - PMC3186417 EDAT- 2011/08/16 06:00 MHDA- 2011/12/14 06:00 PMCR- 2011/08/12 CRDT- 2011/08/16 06:00 PHST- 2011/08/16 06:00 [entrez] PHST- 2011/08/16 06:00 [pubmed] PHST- 2011/12/14 06:00 [medline] PHST- 2011/08/12 00:00 [pmc-release] AID - S0021-9258(20)73862-7 [pii] AID - M111.235473 [pii] AID - 10.1074/jbc.M111.235473 [doi] PST - ppublish SO - J Biol Chem. 2011 Oct 7;286(40):34800-8. doi: 10.1074/jbc.M111.235473. Epub 2011 Aug 12.